TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Extrawell Pharmaceutical Holdings Limited ( (HK:0858) ).
Extrawell Pharmaceutical Holdings Limited has successfully completed the issuance of 160 million new shares under a general mandate, which will alter its shareholding structure. The company is actively pursuing diversification into the healthcare sector, aligning with China’s Healthy China 2030 strategy. This move aims to leverage its existing infrastructure and expertise, targeting emerging markets with less stringent regulatory requirements for healthcare products.
More about Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited operates within the pharmaceutical and healthcare industry, focusing on self-manufactured pharmaceutical products. The company is actively exploring new business opportunities within the healthcare sector, targeting both the PRC and overseas markets.
Average Trading Volume: 18,911,093
Technical Sentiment Signal: Buy
Current Market Cap: HK$289.2M
For an in-depth examination of 0858 stock, go to TipRanks’ Overview page.